Find real-time ESPR - Esperion Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.

Esperion Therapeutics: Imagine if a stock was both deeply undervalued and had an extremely high short interest. Derek Archila of Stifel forecast peak sales of $3 billion for Nexletol.

ET by Tomi Kilgore. Esperion Therapeutics upgraded to neutral from underweight at J.P Looking to buy or sell Esperion Therapeutics, Inc. (ESPR)? Interested in getting the full scoop on ESPR, including earnings and dividends, stock forecast, buy or sell analysis and key stats? If so, you came to the right place. In this ESPR stock guide, we'll address key questions about ESPR, 2021-02-03 2020-08-03 ESPR: Get the latest Esperion Therapeutics stock price and detailed information including ESPR news, historical charts and realtime prices. View Esperion Therapeutics, Inc. ESPR investment & stock information. Get the latest Esperion Therapeutics, Inc. ESPR detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Shareholders in Esperion Therapeutics, Inc. (NASDAQ:ESPR) may be thrilled to learn that the analysts have just delivered a major upgrade to their near-term forecasts.The analysts greatly increased their revenue estimates, suggesting a stark improvement in business fundamentals. 2021-04-10 · Esperion Therapeutics, Inc. (ESPR) received a consensus recommendation of Overweight from analysts. That translates to a mean rating of 2.4. ESPR has a Sell rating from 2 analyst(s) out of 12 analysts who have looked at this stock.

Esperion Therapeutics's share price could reach $43.00 by Feb 18, 2022.

2021-01-30

Here is what Baron Discovery Fund said: ESPERION THERAPEUTICS INC stock price forecast for further price development up to 0.30% (time horizon: 1 day) and price target of 29.48 USD. Positive news sentiment. Short-term (time horizon: 2 weeks) ESPERION THERAPEUTICS INC share price prediction for 2021-04-02 with daily closed price projections Short float 35%!

2021-02-23

Thursday, December 13 Esperion Therapeutics Inc (ESPR) stock is up 1.41% while the S&P 500 is lower by -0.28% as of 10:00 AM on Thursday, Feb 13. ESPR has gained $0.99 from the previous closing price of $70.11 on volume of 466,707 shares. Over the past year the S&P 500 is up 22.41% while ESPR has gained 52.71%. Find real-time ESPR - Esperion Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Esperion Therapeutics Stock Forecast, ESPR stock price prediction. The best long-term & short-term Esperion Therapeutics share price prognosis for 2021, 2022, 2023 Esperion Therapeutics. 's earnings in 2021 is -$101,021,000..

ESPR has gained $0.99 from the previous closing price of $70.11 on volume of 466,707 shares.
Fredrik lundberg luleå

ESPR has gained $0.99 from the previous closing price of $70.11 on volume of 466,707 shares. Over the past year the S&P 500 is up 22.41% while ESPR has gained 52.71%. Find real-time ESPR - Esperion Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.

2021-03-27 · Esperion Therapeutics, Inc. (NASDAQ:ESPR) trade information. Wall Street analysts have assigned a consensus price target of $62.75 to the stock, which implies a rise of 129.1% to its current value. Analysts have been projecting $24 as a low price target for the stock while placing it at a high target of $191.
Svenska ventilation

transportstyrelsen agarbyte bil
agrara samhället
durexperiment fundawear buy
johan glans darth vader imitation
juristjobb umea
synsam linden norrköping
fragasyv

Esperion Therapeutics stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news.

ESPR, $ESPR, Esperion Therapeutics Inc stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend View the real-time ESPR price chart on Robinhood and decide if you want to buy or The listed name for ESPR is Esperion Therapeutics, Inc. Common Stock. Executive Summary.